Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

José Carlos Nicolau

ResearcherPublications, citations & collaboration network

José Carlos Nicolau is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 680 works, 46,488 citations, an h-index of 76 and an i10-index of 264.

680
Works
46,488
Citations
76
h-index
264
i10-index

How has José Carlos Nicolau's publication output changed over time?

ScholarIQpublication output · 2011–2021

Output grew0% over the shown period — from 1 works in 2011 to 1 in 2021.

1
2
1
5
1
1
1
2011201220152017201920202021

What are the most-cited papers on José Carlos Nicolau?

ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
New England Journal of Medicine. 20179,298 CitationsOPEN ACCESS
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andrej Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Mark C. Petrie, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Subodh Verma, Claes Held, David L. DeMets, Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde
New England Journal of Medicine. 20197,005 CitationsOPEN ACCESS
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca, Deepak L. Bhatt, Marc Cohen, Philippe Gabríel Steg, Robert F. Storey, Eva C. Jensen, Giulia Magnani, Sameer Bansilal, M. Polly Fish, KyungAh Im, Olof Bengtsson, Ton Oude Ophuis, Andrzej Budaj, Pierre Théroux, Mikhail Ruda, Christian Hamm, Shinya Goto, Jindřich Špinar, José Carlos Nicolau, Róbert Gábor Kiss, Sabina A. Murphy, Stephen Wiviott, Peter Held, Eugene Braunwald, Marc S. Sabatine
New England Journal of Medicine. 20151,985 CitationsOPEN ACCESS
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker, Jean MacFadyen, Tom Thurén, Brendan M Everett, Peter Libby, Robert J. Glynn, Paul M. Ridker, Alberto Lorenzatti, Henry Krum, George Varigos, Peter Siostrzonek, Peter Sinnaeve, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Nina Gotcheva, Jacques Genest, Yong Huo, Miguel Urina‐Triana, Davor Miličić, Renata Cífková, Riina Vettus, Wolfgang Köenig, S.D. Anker, Athanasios Manolis, Fernando Wyss, Tamás Forster, Axel F. Sigurðsson, Prem Pais, Alessandro Fucili, Hisao Ogawa, Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, John J.P. Kastelein, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Brendan Everett, Les B. Forgosh, Robert J. Glynn, Barry Harris, Peter Libby, M Ligueros, Tom Thurén, Erin A. Bohula, Bindu Charmarthi, Susan Cheng, Sherry Chou, Jacqueline Suk Danik, Graham T. McMahon, Bradley A. Maron, MingMing Ning, Benjamin A. Olenchock, Reena L. Pande, Todd S. Perlstein, Aruna D. Pradhan, Natalia S. Rost, Aneesh B. Singhal, Viviany R. Taqueti, Nancy Wei, Howard A. Burris, Angela Cioffi, Anne Marie Dalseg, Nilanjan Ghosh, Julie R. Gralow, Tina Mayer, Hope S. Rugo, Vance G. Fowler, Ajit P. Limaye, Sara E. Cosgrove, Donald P. Levine, Renato D. Lópes, John Scott, Tom Thurén, M Ligueros, Robert Hilkert, Georgia Tamesby, Carolyn Mickel, Brian Manning, Julian Woelcke, Monique Tan, S Manfreda
The Lancet. 20171,333 CitationsOPEN ACCESS
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow, Eugene Braunwald, Marc P. Bonaca, Sebastián F. Ameriso, Anthony J. Dalby, Mary Polly Fish, Keith A.A. Fox, Leslie Lipka, Xuan Liu, José Carlos Nicolau, A.J. Oude Ophuis, Ernesto Paolasso, Benjamin M. Scirica, Jindřich Špinar, Pierre Théroux, Stephen D. Wiviott, John Strony, Sabina A. Murphy
New England Journal of Medicine. 2012945 CitationsOPEN ACCESS

Related on ScholarIQ

Hospital São Paulo
Institution
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paper
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Paper
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Paper
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paper
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
Paper
470M+ articles · free account